Only thing that might kick start decent share value growth is pray strong interest in Mithra's new contraceptive pill e4 if this were to translate into enough actual sales probably give enough incentive for investors to buy in Mayne . Company's diabolical track record for retail share holders last 5 years it'll need something pretty significant to happen . Optimistic projected earnings earnings " game changing talk" wont cut it means nothing when there's no credibility . Seeing is believing , think company needs to show a net profit report now cant see that happening any time soon especially now we have all the associated Nextstellis costs , better hope it proves a profitable investment it'll have to be cant see how we can afford it not to be , we know it'll be us holding the bag if this is another SR investment gone wrong . Say there'd be plenty sitting on the fence waiting to find out , shares in limbo for good reason given SR / board track record last 5 years .
MYX Price at posting:
23.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)